Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Starting soon Not applicable

Effect of Intracanal Cryotherapy on Pain, Anxiety, and Salivary Irisin After Root Canal Treatment

NCT07889050 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2026-11-01
Last updated
2026-10-22

Condition(s) studied

Postoperative Pain After Endodontic TreatmentDental AnxietyRoot Canal Treatment

Investigational drug(s) / intervention(s)

Intracanal CryotherapyStandard Room-Temperature Irrigation

Intracanal Cryotherapy: Following completion of the standard EndoVac irrigation protocol, a group-specific final irrigation step will be performed. Sterile saline solution, refrigerated at +2°C and further cooled to 2.5°C in an ice-water bath, with temperature verified using a digital thermometer, will be delivered using the EndoVac system. A total of 20 mL of cooled saline will be applied over 5 minutes, with the micro-cannula positioned at working length to ensure effective delivery of the cold irrigant to the apical region via negative pressure.

Standard Room-Temperature Irrigation: Following completion of the standard EndoVac irrigation protocol, a group-specific final irrigation step will be performed. Sterile saline solution prepared at room temperature (20-22°C) will be delivered using the EndoVac system, following the same protocol as the intervention group. A total of 20 mL of room-temperature saline will be applied over 5 minutes, using the same technique and duration.

Study summary

Some people feel pain after a root canal treatment. This study will test whether intracanal cryotherapy, a final rinse of the tooth with cold sterile saline, can reduce this pain compared with a room-temperature rinse.

Previous studies have suggested that intracanal cryotherapy may reduce pain after root canal treatment. In this study, we will examine its effect in a defined group of patients and explore how it works. We will measure the level of irisin, a substance with reported anti-inflammatory properties, in saliva to see whether cryotherapy changes it. We will also look at whether a person's tendency to worry about pain (pain catastrophizing) changes the effect of cryotherapy on pain, and whether dental anxiety is related to pain after treatment.

Adults aged 18 to 65 who need root canal treatment on a single-rooted lower premolar tooth will receive standard single-visit treatment. By chance, 100 participants will be placed in a cold-saline group or a room-temperature-saline group. Thirty healthy volunteers will give one saliva sample for comparison. Participants will complete questionnaires before treatment, rate their pain over the 7 days after treatment, and give saliva samples for irisin measurement.

The main questions this study aims to answer are:

Does intracanal cryotherapy lower pain after root canal treatment? Does it change salivary irisin levels? Does pain catastrophizing change the effect of cryotherapy? Is dental anxiety related to pain after treatment?

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Age 18 to 65 years * Single-rooted, single-canal mandibular premolar teeth with no previous root -canal treatment * Asymptomatic apical periodontitis (Periapical Index score ≥ 3) * Systemically healthy (ASA I-II) * Signed informed consent form * Able to be contacted and attend follow-up appointments * Able to maintain a pain diary * No use of anti-inflammatory medication within the past 3 months Exclusion Criteria: * Pregnancy or breastfeeding * Systemic diseases (diabetes mellitus, cardiovascular disease, renal or hepatic insufficiency) * Use of immunosuppressive therapy * Use of corticosteroids or NSAIDs within the past 3 months * Use of antibiotics within the past 1 month * Presence of periapical abscess or sinus tract * Vertical root fracture * Root perforation * External or internal root resorption * Canal obstruction in the apical third * Periodontal disease (presence of pockets deeper than 3 mm) * Excessive dental hypersensitivity * Bruxism * Occlusal trauma * Mental or psychiatric disorder * Neurological disease affecting pain perception * Allergy to paracetamol * Refusal to participate in the study * Body mass index above 35 kg/m²

Primary outcome measure(s)

  • Postoperative Pain as Assessed by Visual Analog Scale (VAS) — 24 hours after root canal treatment
    Postoperative pain will be self-assessed by participants using a 100 mm Visual Analog Scale (VAS), consisting of a horizontal line where participants mark the point that best represents their level of pain intensity. The left end (0 mm) indicates "no pain" and the right end (100 mm) indicates "the most severe pain I have ever felt in my life." Scores are measured in millimeters, with higher scores indicating greater pain intensity. Participants will record their VAS score in a standardized pain diary at each assessment time point, along with any rescue analgesic (paracetamol 500 mg) use, including time and dose, and any adverse events or unexpected occurrences. A blinded researcher, unaware of group allocation, will telephone participants at each designated time point to record pain scores and remind them to complete the diary.

Trial sites (1)

FacilityCityRegionStatus
Alanya Alaaddin Keykubat University, Faculty of Dentistry Antalya Antalya
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07889050 on ClinicalTrials.gov ↗ ← All trials in Turkey